(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 3.56% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Envista Holdings's revenue in 2026 is $2,808,100,000.On average, 18 Wall Street analysts forecast NVST's revenue for 2026 to be $474,514,623,468, with the lowest NVST revenue forecast at $449,291,795,403, and the highest NVST revenue forecast at $493,228,334,613. On average, 18 Wall Street analysts forecast NVST's revenue for 2027 to be $490,787,415,768, with the lowest NVST revenue forecast at $461,008,205,859, and the highest NVST revenue forecast at $516,335,699,679.
In 2028, NVST is forecast to generate $507,711,119,760 in revenue, with the lowest revenue forecast at $476,630,086,467 and the highest revenue forecast at $540,256,704,360.